ABBV
USDAbbVie Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$212.370
最高
$217.080
最低
$212.370
交易量
6.49M
公司基本面
市值
381.4B
行業
Drug Manufacturers - General
國家
United States
交易統計
平均交易量
5.41M
交易所
NYQ
貨幣
USD
52週範圍
相關新聞
Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235
Citigroup analyst Geoff Meacham maintains AbbVie with a Neutral and lowers the price target from $240 to $235.
JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260
JP Morgan analyst Chris Schott maintains AbbVie with a Overweight and raises the price target from $250 to $260.
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfolio growth.
AbbVie Reports Third-Quarter 2025 Financial Results
AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2025. "AbbVie continues to deliver outstanding results, with ...
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, November...
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib...
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings
Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.
